Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors

INTRODUCTION: Treatment of recurrent primary pediatric brain tumors remains a major challenge, with most children succumbing to their disease. We conducted a prospective phase 2 study investigating the safety and efficacy of pomalidomide (POM) in children and young adults with recurrent and progress...

Descripción completa

Detalles Bibliográficos
Autores principales: Fangusaro, Jason, Cefalo, Maria Giuseppina, Garré, Maria Luisa, Marshall, Lynley V., Massimino, Maura, Benettaib, Bouchra, Biserna, Noha, Poon, Jennifer, Quan, Jackie, Conlin, Erin, Lewandowski, John, Simcock, Mathew, Jeste, Neelum, Hargrave, Darren R., Doz, François, Warren, Katherine E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218626/
https://www.ncbi.nlm.nih.gov/pubmed/34168987
http://dx.doi.org/10.3389/fonc.2021.660892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218626/
https://www.ncbi.nlm.nih.gov/pubmed/34168987
http://dx.doi.org/10.3389/fonc.2021.660892

Ejemplares similares